The KEN SHE Study on HPV-vaccine Efficacy

NCT03675256 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2275

Enrollment

OTHER

Sponsor class

Conditions

Papillomavirus Infections

Interventions

BIOLOGICAL: immediate Gardasil 9, delayed MenVeo vaccine
BIOLOGICAL: immediate MenVeo vaccine, delayed Gardasil 9
BIOLOGICAL: immediate Cervarix, delayed MenVeo vaccine

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]